CONCLUSIONS This meta-analysis offers compelling evidence for the strong efficacy of retatrutide in enhancing glycemic management and supporting weight reduction among individuals with diabetes and/or obesity who also have chronic kidney disease
This jargon just means that it is an agent that acts just like a substance that our body produces, called GLP-1
Weight Loss Results Injectable GLP-1 medications remain among the most effective weight-loss treatments available
If swallowed, the molecule would be broken down before it could be absorbed into the bloodstream in meaningful quantities, rendering it therapeutically ineffective
Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, et al
Without insurance, $149/month at the lowest dose